ML786 is a potent and orally active Raf inhibitor with IC50 values of 2.1, 4.2, and 2.5 nM against V600EΔB-Raf, wtB-Raf, and C-Raf, respectively. It also inhibits Abl-1, DDR2, EPHA2, VEGFR2/KDR/Flk-1, and RET (IC50 = <0.5, 7.0, 11, 6.2, and 0.8 nM, respectively). ML786 can be used in cancer research.